AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
NeuroOne Medical Technologies Corporation Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001V0L7S3
0.92▼ 0.06 (-6.19%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
0.98
Day's Range
0.88 – 1.00
52-Week Range
0.55 – 5.46
Volume
72.0K
Avg Volume
156.9K
Share Statistics
Shares Outstanding
Employees
18
Exchange
XNAS
Listed
2012-11-09
Share count as of August 11, 2026

NeuroOne Medical Technologies Corporation Common Stock (NMTC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about NeuroOne Medical Technologies Corporation Common Stock (NMTC)
What is NeuroOne Medical Technologies Corporation Common Stock's Market Cap?
NeuroOne Medical Technologies Corporation Common Stock's Market Cap is $8.4M, based on as-reported figures from SEC (XBRL) filings.
What is NeuroOne Medical Technologies Corporation Common Stock's Price / Sales?
NeuroOne Medical Technologies Corporation Common Stock's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is NeuroOne Medical Technologies Corporation Common Stock's Revenue (TTM)?
NeuroOne Medical Technologies Corporation Common Stock's Revenue (TTM) is $9.2M, based on as-reported figures from SEC (XBRL) filings.
What is NeuroOne Medical Technologies Corporation Common Stock's Net Income (TTM)?
NeuroOne Medical Technologies Corporation Common Stock's Net Income (TTM) is -$6.9M, based on as-reported figures from SEC (XBRL) filings.
What is NeuroOne Medical Technologies Corporation Common Stock's EBITDA?
NeuroOne Medical Technologies Corporation Common Stock's EBITDA is -$7.1M, based on as-reported figures from SEC (XBRL) filings.
What is NeuroOne Medical Technologies Corporation Common Stock's Diluted EPS (TTM)?
NeuroOne Medical Technologies Corporation Common Stock's Diluted EPS (TTM) is -0.76, based on as-reported figures from SEC (XBRL) filings.
What is NeuroOne Medical Technologies Corporation Common Stock's EBITDA Margin?
NeuroOne Medical Technologies Corporation Common Stock's EBITDA Margin is -77.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NMTCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Product revenue——
YoY growth+16.3%——+906.6%
Cost of product revenue——
Product gross profit——
% of revenue59.9%——55.8%
License revenue————
Operating expenses:
Selling, general and administrative——
Research and development——
Total operating expenses——
% of revenue182.8%——105.8%
Loss from operations——
% of revenue-122.9%——-50.0%
Fair value change in warrant liability——
Financing costs———
Other income——
Loss before income taxes——
Net loss
% of revenue-101.7%——-59.1%
Basic (in Dollars per share)———
Diluted (in Dollars per share)———